摘要
目的:研究丙戊酸钠(VPA)对多发性骨髓瘤细胞株KM3细胞增殖和凋亡的影响,探讨其抗多发性骨髓瘤细胞的分子生物学机制。方法:采用MTT法检测细胞增殖,流式细胞仪检测凋亡率,RT-PCR检测KM3细胞VEGFR mRNA的表达;采用免疫细胞化学法观察KM3细胞VEGFR、ac-H4蛋白的表达。结果:VPA可明显抑制KM3细胞增殖,且具有时间剂量依赖性(P<0.05);不同浓度VPA处理48 h可以明显诱导细胞凋亡,具有剂量依赖性(P<0.05),VPA(0.5、1.0、2.0、4.0 mmol/L)诱导总凋亡率分别为(11.77±4.64)%、(22.13±1.20)%、(23.95±2.57)%和(42.72±4.61)%;RT-PCR结果显示,KM3细胞仅表达VEGFR-1(flt-1),且VPA能在mRNA水平抑制VEGFR-1的表达;免疫细胞化学结果显示,VPA(4 mmol/L)作用48 h后,KM3细胞中ac-H4吸光度值明显增加而VEGFR-1的吸光度明显降低(P<0.05)。结论:VPA通过增加组蛋白乙酰化程度,下调骨髓瘤细胞表面VEGFR的表达,对KM3细胞的增殖起抑制作用。
Objective:To define the effects of VPA on multiple myeloma cell line KM3 cells in vitro and the underlying mechanism of VPA in the treatment of MM were investigated. Method: KM3 cells were cultured in RP- MI1640 medium and treated with VPA in different concentrations. Cell proliferation was measured by 3-[4,5-dim- ethyl-thiazol-2-yl]-2, 5-dipbenyl tetrazolium bromide (MTT) assay. AnnexinV and PI staining were used to detect the apoptosis rates, the mRNA level of VEGFR was determined by RT-PCR, and immunocytochemistry was used to detect the protein level of acetylated-histone H4 (ac-histone H4) and VEGFR. Result:The proliferation rate of KM3 cells in VPA-treated group decreased in a time-dose dependent manner ( P 〈0.05). And the AnnexinV and PI staining showed VPA could induce apoptosis of KM3 cells. After treatment with VPA (0.5, 1.0, 2.0 and 4.0 mmol/L) for48 h, the apoptosis rates of KM3 ceils were (11. 77±4. 64)%, (22. 13±1. 20)%, (23. 95±2.57) % and (42. 72±4.61)% respectively. The RT-PCR results demonstrated the KM3 cells only expressed VEGFR-1 and VEGFR expression decreased in VPA (0.5, 1.0, 2.0 and 4.0 mmol/L for 48 h) treated groups compared with control ( P 〈 0. 05). Results of immunocytochemistry showed the protein of ac-histone H4 increased significantly in VPA (4 mmol/L for 48 h) treated group whereas the VEGFR-1/fh-1 expression decreased ( P 〈0.05). Conclusion: VPA, as an histone deacetylase inhibitor, can increase the expression of ae-histone H4 and inhibit the expression of VEGFR-1 in KM3 cells and it plays an important role in regulating proliferation and apoptosis of multiple myeloma cell line KM3 cells in vitro.
出处
《临床血液学杂志》
CAS
2009年第3期266-269,共4页
Journal of Clinical Hematology
基金
山东省自然科学基金资助(No:Y2006c63)